Clinical Trial Update: Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 safety study using a genetically modified adenovirus in ovarian cancer and primary peritoneal cancer has completed. The trial was conducted to assess …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Genetically Modified Adenovirus (adenovirus vector)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 1 | Status: COMPLETED